Literature DB >> 12885123

Synthesis of triazole nucleoside derivatives.

Zicheng Li1, Shuhua Chen, Ning Jiang, Gang Cui.   

Abstract

5'-O-Mesyl-2',3'-O-isopropylidene ribonucleosides (4 and 12) were converted to their 5'-substituted nucleosides in good yields by reacted with NaN3 or KI. 2',3'-O-Isopropylidene ribonucleosides (3 and 11) were prepared in good yields from ribonucleosides 1 and 2 with a reaction mixture of acetone and triethyl orthoformate instead of using acetone diethyl acetal. Compound 1 or 2 was treated with 2-acetoxyisobutyryl halide (Cl or Br) to give 1-[2-O-acetyl-3-halo-3-deoxy-5-O-(2,5,5-trimethyl-1,3-dioxolan-4-on-2-yl)-beta-D-xylofuranosyl]-1,2,4-triazole-3-carboxamide (19, 22, and 23) in high yields. Instead of using 2-acetoxyisobutyryl bromide, the mixture of 2-acetoxyisobutyryl chloride and NaBr was employed in the synthesis of 22 and 23. Treatment of 19 with an activated Zn/Cu couple and deprotection gave 2',3'-anhydro nucleoside (21), and treatment of 22 and 23 with an activated Zn/Cu couple and a little of HOAc and deprotection gave corresponding 2',3'-unsaturated triazole nucleosides (24 and 25), respectively. The biological activity of the compounds (7-10, 15-18, and 24) was examined in human liver cancer cells (A-549), lung cancer cells (BEL-7402), and Flu-A cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885123     DOI: 10.1081/NCN-120022032

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

Review 1.  Advance of structural modification of nucleosides scaffold.

Authors:  Xia Lin; Chunxian Liang; Lianjia Zou; Yanchun Yin; Jianyi Wang; Dandan Chen; Weisen Lan
Journal:  Eur J Med Chem       Date:  2021-01-30       Impact factor: 6.514

2.  Crystal structure of 4-amino-1-benzyl-1,2,4-triazolin-5-one.

Authors:  Gerhard Laus; Volker Kahlenberg; Herwig Schottenberger
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.